These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 34191054)
1. [Inhaled budesonide in the treatment of COVID-19]. Kluge S; Nitschmann S; Scherer M Internist (Berl); 2021 Aug; 62(8):887-889. PubMed ID: 34191054 [No Abstract] [Full Text] [Related]
2. Inhaled budesonide for early treatment of COVID-19. Zeitlinger M; Idzko M Lancet Respir Med; 2021 Jul; 9(7):e59. PubMed ID: 33991506 [No Abstract] [Full Text] [Related]
3. Inhaled budesonide for early treatment of COVID-19. Choi JC; Kim WY Lancet Respir Med; 2021 Jul; 9(7):e60. PubMed ID: 33991507 [No Abstract] [Full Text] [Related]
4. Inhaled budesonide for early treatment of COVID-19. San-Juan R; Fernández-Ruiz M; López-Medrano F; Aguado JM Lancet Respir Med; 2021 Jul; 9(7):e58. PubMed ID: 33991508 [No Abstract] [Full Text] [Related]
5. Is inhaled budesonide an effective treatment for patients with mild early symptoms of COVID-19? Kareemi H; Rosenberg H; Yadav K CJEM; 2021 Sep; 23(5):611-612. PubMed ID: 34279822 [No Abstract] [Full Text] [Related]
6. Add-on inhaled budesonide in the treatment of hospitalised patients with COVID-19: a randomised clinical trial. Agustí A; De Stefano G; Levi A; Muñoz X; Romero-Mesones C; Sibila O; Lopez-Giraldo A; Plaza Moral V; Curto E; Echazarreta AL; Márquez SE; Pascual-Guàrdia S; Santos S; Marin A; Valdés L; Saldarini F; Salgado C; Casanovas G; Varea S; Ríos J; Faner R Eur Respir J; 2022 Mar; 59(3):. PubMed ID: 35144989 [TBL] [Abstract][Full Text] [Related]
7. Early treatment with inhaled budesonide to prevent clinical deterioration in patients with COVID-19. Agusti A; Torres F; Faner R Lancet Respir Med; 2021 Jul; 9(7):682-683. PubMed ID: 33844998 [No Abstract] [Full Text] [Related]
8. High-dose budesonide for early COVID-19. Lipworth B; Chan R; Misirovs R Lancet; 2021 Dec; 398(10317):2147. PubMed ID: 34895529 [No Abstract] [Full Text] [Related]
9. High-dose budesonide for early COVID-19. Berezowski I; Patel J; Shaw M; Pourmand A Lancet; 2021 Dec; 398(10317):2146-2147. PubMed ID: 34895527 [No Abstract] [Full Text] [Related]
10. Inhaled Budesonide Reduces the Risk of Emergency Department Evaluation or Hospitalization in Early COVID-19. Ebell MH Am Fam Physician; 2021 Aug; 104(2):207-208. PubMed ID: 34383442 [No Abstract] [Full Text] [Related]
11. Inhaled budesonide for mild COVID-19. Is there more to it than just airways? Rathi S; Ish P; Kalantri A; Kalantri S Adv Respir Med; 2021; 89(5):552-553. PubMed ID: 34668186 [No Abstract] [Full Text] [Related]